Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease.

MLA

Gallo, Widet, et al. “Replication Study Reveals MiR-483-5p as an Important Target in Prevention of Cardiometabolic Disease.” BMC Cardiovascular Disorders, vol. 21, no. 1, Apr. 2021, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12872-021-01964-0.

APA

Gallo, W., Ottosson, F., Kennbäck, C., Jujic, A., Esguerra, J. L. S., Eliasson, L., & Melander, O. (2021). Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease. BMC Cardiovascular Disorders, 21(1), 1–7. https://doi.org/10.1186/s12872-021-01964-0

Chicago

Gallo, Widet, Filip Ottosson, Cecilia Kennbäck, Amra Jujic, Jonathan Lou S. Esguerra, Lena Eliasson, and Olle Melander. 2021. “Replication Study Reveals MiR-483-5p as an Important Target in Prevention of Cardiometabolic Disease.” BMC Cardiovascular Disorders 21 (1): 1–7. doi:10.1186/s12872-021-01964-0.